瞭望 | 基因经济：万亿级产业培育路径

Core Insights - Gene technology is driving a new industrial revolution, transitioning from research to clinical applications and expanding into consumer-level home testing [1][3] - China is leveraging its vast market advantages to drive technological innovation and application in precision medicine and health management, aiming to seize the future of the bio-economy [1][6] - The rapid development of the gene testing industry is reshaping future industry trajectories, with a focus on faster, lower-cost, and more precise testing [3][4] Industry Development - The gene technology sector has entered a fast development phase, with gene testing becoming a core component due to its significant foundational role and practical applications [3][4] - The market price for whole genome sequencing has dramatically decreased from over $30 billion and 13 years for the first human genome to between $1,000 and $10,000 today [4][5] - The potential market size for whole genome sequencing in China alone is estimated to reach trillions of yuan [5] Social Impact - Recent initiatives in Hebei province have successfully implemented non-invasive prenatal genetic testing and free screening for hereditary deafness, significantly controlling severe birth defects [5] - The economic benefits of these health initiatives have been substantial, with a cost-effectiveness ratio of 1:16.73 and 1:15.06 for the respective screening programs [5] Safety and Security - Gene technology plays a crucial role in national security across multiple dimensions, including population, biology, food, ecology, economy, technology, data, and culture [5][6] - High-throughput sequencing technology has been instrumental in identifying new pathogens like SARS and COVID-19, supporting biological safety warning systems [5] International Influence - Domestic sequencing instruments have been deployed across six continents, providing essential support and services to hospitals, universities, and public health institutions globally [5][6] - Chinese scientists are actively involved in planning and constructing biobanks in various countries, contributing to the establishment of a global health community [5][6] Strategic Initiatives - The industry is encouraged to adopt a "Gene+" action plan to integrate gene technology deeply into various economic and social sectors, fostering a cycle of innovation and application [6][8] - There is a call for the establishment of national or regional biobank resources to support gene technology research and enhance sample management and sharing [6][8] - Investment in the entire gene industry chain, including gene testing, synthesis, and therapy, is essential for strengthening domestic capabilities [6][8]